XGN - Exagen Announces Campaign for Lupus Awareness Month | Benzinga
CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work being done to help those suffering from Systemic Lupus Erythematosus (SLE).
Lupus Awareness Month occurs every May and is an important platform for lupus-focused organizations to educate and advocate for those affected by this complex condition. Lupus is a disease that AVISE® testing is specially equipped to help with and today marks the start of a month-long awareness campaign.
Starting this week, Exagen will be raising awareness in a variety of ways:
- Exagen has partnered with the Lupus Foundation of America, which is the largest national organization devoted to improving the quality of life for all people affected by lupus through programs of research, education, support and advocacy.
- The Exagen team will be sharing educational content throughout the month on multiple social media platforms. The content will highlight the multi-year journey to diagnosis and the impact that a delayed diagnosis can have financially, emotionally and physically.
- Exagen will work to provide encouragement to the 1.5 million Americans suffering with lupus by providing insights into the future of lupus diagnostics and therapies on AVISETest.com.
This campaign will run through the end of the month.
"On average, lupus patients in the United States experience a six-year ...